|
Market Closed -
OTC Markets
23:59:57 18/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 32.90 USD | -1.70% |
|
-4.95% | +14.24% |
| 11-17 | Evans and Partners Downgrades CSL to Neutral, Adjusts Price Target to AU$197.24 | MT |
| 11-04 | ASX Midday Sector Utilities Stocks Rise, Health Care Struggles | MT |
Company Valuation: CSL Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 89,299 | 89,052 | 95,184 | 76,024 | 38,015 | 64,097 | - | - |
| Change | - | -0.28% | 6.89% | -20.13% | -50% | 68.61% | - | - |
| Enterprise Value (EV) 1 | 88,520 | 99,731 | 105,710 | 85,005 | 47,398 | 73,312 | 72,923 | 72,338 |
| Change | - | 12.66% | 5.99% | -19.59% | -44.24% | 54.67% | -0.53% | -0.8% |
| P/E | 38.6x | 40.8x | 36.1x | 25.4x | -14.8x | 22x | 20x | 19.1x |
| PBR | 6.13x | 5.64x | 5.48x | 3.93x | 2.57x | 4x | 3.66x | 3.33x |
| PEG | - | -7.25x | 1.8x | 1.9x | 0x | -0x | 1.9x | 3.89x |
| Capitalization / Revenue | 8.45x | 6.69x | 6.43x | 4.89x | 2.41x | 4.07x | 3.93x | 3.77x |
| EV / Revenue | 8.38x | 7.49x | 7.14x | 5.46x | 3x | 4.65x | 4.47x | 4.26x |
| EV / EBITDA | 24.6x | 25.6x | 22.3x | 16.5x | 10.7x | 14.4x | 13.7x | 13x |
| EV / EBIT | 30.2x | 32.5x | 27.7x | 19x | 10.3x | 16.8x | 15.9x | 15x |
| EV / FCF | 57.1x | 72.6x | 55.2x | 29.1x | 16.5x | 23.3x | 24.8x | 23.4x |
| FCF Yield | 1.75% | 1.38% | 1.81% | 3.44% | 6.05% | 4.29% | 4.03% | 4.26% |
| Dividend per Share 2 | 2.22 | 2.36 | 2.64 | 2.92 | 2.92 | 3.008 | 3.182 | 3.408 |
| Rate of return | 1.2% | 1.28% | 1.34% | 1.86% | 3.68% | 2.25% | 2.38% | 2.55% |
| EPS 2 | 4.8 | 4.53 | 5.45 | 6.17 | -5.35 | 6.071 | 6.694 | 7.023 |
| Distribution rate | 46.3% | 52.1% | 48.4% | 47.3% | -54.6% | 49.5% | 47.5% | 48.5% |
| Net sales 1 | 10,562 | 13,310 | 14,800 | 15,558 | 15,797 | 15,759 | 16,307 | 16,991 |
| EBITDA 1 | 3,596 | 3,900 | 4,750 | 5,151 | 4,438 | 5,089 | 5,317 | 5,583 |
| EBIT 1 | 2,927 | 3,069 | 3,812 | 4,468 | 4,620 | 4,368 | 4,583 | 4,809 |
| Net income 1 | 2,255 | 2,194 | 2,642 | 3,002 | -2,579 | 2,821 | 3,133 | 3,325 |
| Net Debt 1 | -778.6 | 10,679 | 10,526 | 8,981 | 9,383 | 9,215 | 8,826 | 8,241 |
| Reference price 2 | 185.38 | 184.61 | 196.96 | 157.01 | 79.38 | 133.84 | 133.84 | 133.84 |
| Nbr of stocks (in thousands) | 481,706 | 482,372 | 483,253 | 484,212 | 478,912 | 478,912 | - | - |
| Announcement Date | 8/16/22 A | 8/14/23 A | 8/12/24 A | 8/18/25 A | 8/17/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 40.47x | 13.71x | 29.06x | 0.49% | 1,232B | ||
| 39.91x | 6.7x | 18.85x | 1.95% | 656B | ||
| 36.46x | 8.39x | 17.35x | 2.41% | 506B | ||
| 21.68x | 5.25x | 13.15x | 2.48% | 382B | ||
| 97.8x | 5.62x | 23.94x | 2.47% | 340B | ||
| 23.54x | 5.68x | 13.81x | 2.8% | 294B | ||
| 23.52x | 4.72x | 13.42x | 1.86% | 278B | ||
| 22.92x | 7.08x | 13.01x | 2.27% | 240B | ||
| -39.74x | 7.35x | 46.29x | 1.95% | 210B | ||
| Average | 29.62x | 7.17x | 20.99x | 2.08% | 460B | |
| Weighted average by Cap. | 35.44x | 8.62x | 21.93x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CSL Stock
- CSLLY Stock
- Valuation CSL Limited
Select your edition
All financial news and data tailored to specific country editions
















